T 0334/10 (Enovin/JANSSEN PHARMACEUTICA) of 13.11.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T033410.20141113
- Date of decision
- 13 November 2014
- Case number
- T 0334/10
- Petition for review of
- -
- Application number
- 99938261.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Neurotrophic growth factor
- Applicant name
- Janssen Pharmaceutica NV
- Opponent name
- Biogen Idec Inc.
NsGene A/S - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- "Main request - requirements of the EPC met (yes)"
- Catchword
- -
- Citing cases
- T 0479/24
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the main request filed during the oral proceedings on 13 November 2014 and a description and figures to be adapted thereto.